Grayscale Challenges SEC Delay on Digital Large Cap Fund ETF Listing
Cointelegraph reports that Grayscale attorneys filed a formal complaint against the SEC on Tuesday. The complaint addresses the regulator's decision to halt the Digital Large Cap Fund ETF listing despite initial approval. The SEC's Division of Trading and Markets approved the ETF proposal under delegated authority. However, the SEC's Office of the Secretary immediately placed the decision under review.
Grayscale's legal team argues this violates statutory approval deadlines set by federal regulations. The attorneys state that under Section 19(b)(2)(D), delayed decisions result in automatic approval. The Digital Large Cap Fund manages $755 million in assets across Bitcoin, Ethereum, XRP, Solana, and Cardano.
Why This Matters
The regulatory standoff affects thousands of current investors waiting for enhanced liquidity. The fund would become the largest multi-token digital asset ETF globally. The product tracks the CoinDesk 5 Index with Bitcoin comprising 80% of holdings.
We previously reported that BlackRock's iShares Bitcoin ETF achieved record status as institutional demand for crypto exposure grows substantially. Bloomberg ETF analysts assigned 95% approval odds to multi-asset crypto ETFs before the regulatory review began. The delay prevents retail investors from accessing diversified crypto exposure through traditional brokerage accounts.
Investment firms view this as a test case for future altcoin ETF approvals. Grayscale called the decision "unexpected" given the changing regulatory landscape. The firm previously won a court battle that led to Bitcoin spot ETF approvals in January 2024.
Industry Implications
The regulatory pause reflects broader tensions over crypto asset classification policies. Industry observers expect the SEC to establish formal listing standards for digital asset ETFs. Current SEC Chairman Paul Atkins has advocated for transparent regulatory frameworks over enforcement-based oversight.
Multiple asset managers including Bitwise, Franklin Templeton, and Hashdex await similar decisions on crypto basket fund applications. The Bitwise 10 Crypto Index Fund conversion deadline falls on July 31, 2025. Analysts believe the SEC may approve multiple products simultaneously under unified standards.
It is reported that commissioners can request reviews of delegated authority decisions at any time. The review process lacks defined timelines, creating uncertainty for pending applications. Traditional finance institutions monitor these developments as they consider expanding crypto investment offerings.
The outcome could determine whether altcoin ETFs receive expedited approval processes or face continued regulatory scrutiny. Industry experts predict resolution by late 2025 as the SEC finalizes comprehensive crypto ETF policies.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Apple Pre-sale Tracker: iPhone 18 Pro Series Shows Weak Overseas Demand Signals, Duo Review Positive but Hardware Lags Behind
According to a survey by Jefferies, after the launch of the iPhone 18 Pro, delivery wait times in the four major markets—the US, UK, Germany, and Japan—have shortened by 5 to 11 days compared to last year, with no wait time in the US. Given stable production capacity, this is a clear sign of weak demand. Although the China and Hong Kong markets have performed better against the trend, there are still suspicions of speculative stockpiling. The new foldable Duo has been praised for its software experience, but its $2,000 price tag comes with a 254-gram body and dual-camera setup, leaving its hardware lagging significantly behind Android competitors. Jefferies maintains an "underperform" rating, with a target price implying a 21% downside from the current level.
UBS Health Benefit Survey: Elevance Health (ELV.US) Leads, U.S. Employers Prepare for Rising Medical Costs
In the annual survey by UBS for employee benefits management institutions, Elevance Health (ELV.US) emerged as the highest-rated US health insurance company.

LINK Targets $11.50 as LINK/BTC Approaches a Critical Breakout Zone

Solana breaks resistance, holds above $100 as analysts target $147